FDA and global regulatory affairs, consumer health, and professional development


Expert guidance for industry professionals and clear, reliable information for patients and consumers

Medical Devices
Pharma square image
Biologics Square Image
Combination Products
In Vitro Diagnostics square

What Are Early Recall Alerts?

Recall Communication “Early Alerts” Note: This summary is based on an FDA communication attributed to Michelle Tarver, M.D., Ph.D., director of the Center for Devices and Radiological Health (CDRH). In November 2024 the U.S. Food and Drug Administration’s Center for...

Urgent Recall Alert for BD Alaris Infusion Sets

Class I Recall (Correction) The FDA has issued an early alert to healthcare providers and patients regarding a performance issue affecting BD Alaris Pump Module model 8100, used with specific compatible infusion sets. BD, through its subsidiary CareFusion, has...

Recall Alert: AirLife/Vyaire Infant Breathing Systems

Class I Recall AirLife and manufacturer Vyaire are recalling specific Infant Heated Wire Circuits due to the risk that accessory adapters may disconnect during use, especially once the system reaches operating temperature. This could lead to serious injury or death,...

Avanos Recalls Ballard Closed Suction Systems

May result in non-sterile devices Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks,...

EPA Proposes Rollback of EtO Sterilization Emissions Limits

EPA Proposes Rollback of Ethylene Oxide Sterilization Emissions LimitsThe U.S. Environmental Protection Agency has proposed weakening restrictions on emissions of ethylene oxide (EtO) from commercial sterilization facilities that sterilize medical devices. EtO plays a...

FDA Approves Novel Device for Pancreatic Cancer Treatment

FDA Approves Novel Device for Pancreatic Cancer Treatment The U.S. Food and Drug Administration has approved Optune Pax, a first-of-its-kind medical device designed to treat adult patients with locally advanced pancreatic cancer. Developed by Novocure, the portable...

When Apparel Becomes a Medical Device

Lessons from FDA’s Breast Binder Warning Letters In December 2025, the FDA issued warning letters to several companies selling breast binders and chest compression garments online. The agency concluded that marketing claims on company websites, like statements about...

Labeling Correction for TRUE METRIX® Blood Glucose Meters

Labeling Correction for TRUE METRIX® Blood Glucose Meters Highlights the Critical Role of Clear Error Messaging Trividia Health, Inc. has initiated a labeling correction affecting all TRUE METRIX®, TRUE METRIX AIR®, TRUE METRIX GO®, and TRUE METRIX PRO® blood glucose...

FDA Approves First Generic Fenbendazole Oral Suspension

Defendazole™ (fenbendazole) 10% Oral Suspension The U.S. Food and Drug Administration has approved Defendazole™ (fenbendazole) 10% oral suspension, the first FDA-approved generic fenbendazole dewormer for use in beef and dairy cattle and goats. Defendazole is...

FDA Testosterone Panel Sparks Concern

Concerns Over Sudden Regulatory Shift The FDA’s December 2025 expert panel has recommended sweeping changes to testosterone regulation – a sharp departure from the agency’s long-standing cautionary stance for the hormone. The panel urged the FDA to broaden...

Testosterone Regulation Takes a Sharp Turn

Why FDA’s December Panel Raises Red Flags Regulatory Analysis The FDA’s regulation of testosterone therapy has long been a model of cautious, evidence-based policymaking. For more than a decade, the agency maintained a consistent position: testosterone was approved...

How U.S. Testosterone Regulation Reached a Crossroads

How U.S. Testosterone Regulation Reached a Crossroads The FDA’s approach to testosterone therapy has undergone one of the most unusual and dramatic evolutions in modern drug regulation. What began as a cautious, evidence-driven posture in 2014 has, by late 2025,...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

FDA Testosterone Panel Sparks Concern

Concerns Over Sudden Regulatory Shift The FDA’s December 2025 expert panel has recommended sweeping changes to testosterone regulation – a sharp departure from the agency’s long-standing cautionary stance for the hormone. The panel urged the FDA to broaden...

Testosterone Regulation Takes a Sharp Turn

Why FDA’s December Panel Raises Red Flags Regulatory Analysis The FDA’s regulation of testosterone therapy has long been a model of cautious, evidence-based policymaking. For more than a decade, the agency maintained a consistent position: testosterone was approved...

How U.S. Testosterone Regulation Reached a Crossroads

How U.S. Testosterone Regulation Reached a Crossroads The FDA’s approach to testosterone therapy has undergone one of the most unusual and dramatic evolutions in modern drug regulation. What began as a cautious, evidence-driven posture in 2014 has, by late 2025,...

Has Industry Self-Regulation Been Effective? 

Has Industry Self-Regulation Been Effective?  Supplement industry self-regulation has helped in limited ways, but it has not been sufficient to ensure reliable safety.  What has worked  Voluntary GMP certifications (e.g., NSF, USP, Informed Choice)  A minority of...

Global Medical Device Regulation
Global Regulatory
Regulatory Information Management Systems
RIMS Architecture tile square
RIMS for Small and Emerging Businesses
RIMS Readiness Self-Assessment
QMSR Inspections tile
QMSR Implementation Strategies tile
QMSR Terms and Definitions Tile
Affected QMSR regulations and standards tile
QMSR for small manufacturers tile
Medical Device Recalls
Medical Device Warning Letters 1
Pharma Recalls
Pharma Warning Letters
Global Regulatory
Pharma Innovation

Welcome to Medical Devices and Pharma, a website dedicated to providing timely and relevant medical device and pharma information to the regulated medical device and pharmaceutical industries, and consumers of those products.

Our goal is to provide organized, clearly written information from regulatory affairs and consumer perspectives.

  • Key information from the Food and Drug Administration (FDA), the federal regulatory agency responsible for providing oversight over the industries and assuring the safety and efficacy of their products.
  • Regulatory services for compliance, market access, and crisis management
  • Information about innovation, including new products cleared for use in the U.S. market.
  • News stories with topics ranging from product issues to market trends.

Perhaps most importantly, we will strive to maintain vigilance over product issues and their impacts. Check back here for consumer news, product alerts, and current litigation.

Artificial Intelligence

Discover how Artificial Intelligence is revolutionizing the medical device and pharmaceutical industries.

Stay up-to-date with the latest advancements and breakthroughs that are shaping the future of healthcare.

QMSR - Quality Management System Regulation

The U.S. Food and Drug Administration (FDA) has introduced significant updates to its regulatory framework for medical device manufacturers with the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR).

This modernization aligns with global standards, streamlining compliance for manufacturers who market devices internationally while maintaining a strong focus on patient safety and product quality.

Quality Management System Regulation - QMSR

Regulatory Information Management Systems - RIMS

Medical Devices
Pharma square image
Combination Products

A veteran-owned business
located in
Iowa’s Cedar Valley